medRxivGenetic & Genomic MedicinePreprint
ANALYSIS OF GLOMERULAR TRANSCRIPTOMES FROM NEPHROTIC PATIENTS SUGGEST APOL1 RISK VARIANTS IMPACT PARIETAL EPITHELIAL CELLS
Agustin Gonzalez‐VicenteiD, Dana C. CrawfordiD, William S. BushiD, Zhenzhen Wu, Leslie A. BruggemaniD, Viji NairiD, Felix H. EichingeriD, Oliver WesselyiD, Matthias KretzleriD, John F. O’TooleiD, John R. SedoriD, Kidney Precision Medicine Project, Nephrotic Syndrome Study Network
Abstract
The disproportionate risk for idiopathic proteinuric podocytopathies in Black people is explained, in part, by the presence of two risk alleles (G1 or G2) in the APOL1 gene. The pathogenic mechanisms responsible for this genetic association remain incompletely understood. We analyzed glomerular RNASeq transcriptomes from patients with idiopathic nephrotic syndrome of which 72 had inferred African ancestry (AA) and 152 did not (noAA). Using gene coexpression networks we found a significant association between APOL1 risk allele number and the coexpression metamodule 2 (MM2), even after adjustment for eGFR and proteinuria at biopsy. Unadjusted Kaplan-Meier curves showed that unlike noAA, AA with the highest tertile of MM2 gene activation scores were less likely to achieve complete remission (p[≤]0.014). Characteristic direction (ChDir) identified a signature of 1481 genes, which separated patients with APOL1 risk alleles from those homozygous for reference APOL1. Only in AA, the tertile with the highest activation scores of these 1481 genes was less likely to achieve complete remission (p[≤]0.022) and showed a trend to faster progression to the composite event of kidney failure or loss of 40% eGFR (p[≤]0.099). The MM2 and ChDir genes significantly overlapped and were both enriched for Epithelial Mesenchymal Transition and inflammation terms. Finally, MM2 significantly overlapped with a parietal epithelial cell (PEC)-identity gene signature but not with a podocyte identity signature. Podocytes expressing variant APOL1s may generate inflammatory signals that activate PECs by paracrine mechanisms contributing to APOL1 nephropathy.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- APOL1 kidney risk variants in glomerular diseases modeled in transgenic mice
T. Yoshida, K. Z. Latt, … J. B. Kopp·bioRxiv·Mar 27, 2023
- Strong protective effect of the APOL1 p.N264K variant against G2-associated FSGS and kidney disease
Yask Gupta, David J. Friedman, … Simone Sanna‐Cherchi·Nature CommunicationsPeer-reviewed·Nov 30, 2023
- Meta-analyses of the NEPTUNE dataset related to high and low risk FSGS and cellular APOL1 models identifies Calcium signalling, mTOR signaling and inflammation-associated pathways as operative in APOL1-mediated kidney disease.
Wasco Wruck, Chantelle Thimm, … James Adjaye·bioRxiv·Jul 31, 2026
- Glomerular Elastic Modulus and Gene Expression PatternsDefine Two Phases of Alport Nephropathy
J. Yoon, Z. Liu, … R. T. Miller·bioRxiv·Feb 26, 2024
- APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy
L. A. Bruggeman, Z. Wu, … J. R. Sedor·bioRxiv·Apr 18, 2019
- Phenome-wide analysis of APOL1 risk variants reveals associations between one combination of haplotypes and multiple disease phenotypes in addition to chronic kidney disease
Walt E. Adamson, Harry A. Noyes, … Annette MacLeod·medRxiv·Feb 19, 2023